France In-Vitro Diagnostic Market is predicted to reach USD 2.61 Billion by 2030

According to the study by Next Move Strategy Consulting, the France In-Vitro Diagnostics Market size is predicted to reach USD 2.61 billion, at a CAGR of 2.7% by 2030.

Request a FREE Sample: https://www.nextmsc.com/france-in-vitro-diagnostic-market/request-sample

The growth of the in-vitro diagnostics market in France is driven by the increasing burden of chronic diseases such as infectious diseases, diabetes, cardiovascular disorders, cancers, and others in the country.

The collaborative efforts between the medical diagnostic companies, backed by government funding, further drives advancements in research and development in in-vitro diagnostics techniques.

The promising players operating in the France in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.